Cargando…
Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome
In the current era, the antithrombotic treatment of patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) includes standard aspirin, and one of the potent P2Y(12) inhibitors ticagrelor or prasugrel. The optimal timing of ticagrelor has not been adequately studied, while prasugrel...
Autores principales: | Camaro, Cyril, Damman, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464603/ https://www.ncbi.nlm.nih.gov/pubmed/32784868 http://dx.doi.org/10.3390/jcm9082578 |
Ejemplares similares
-
Recent developments in diagnosis and risk stratification of non-ST-elevation acute coronary syndrome
por: Aarts, G. W. A., et al.
Publicado: (2020) -
Safety of Antiplatelet Pretreatment in Non-ST-segment Elevation Acute Coronary Syndrome
por: Torres-Ruiz, G, et al.
Publicado: (2023) -
Rule-out of non-ST-segment elevation acute coronary syndrome by a single, pre-hospital troponin measurement: a randomized trial
por: Camaro, Cyril, et al.
Publicado: (2023) -
Treatment strategies and outcomes in patients with non-ST-elevation acute coronary syndrome in the Netherlands
por: Damman, P., et al.
Publicado: (2018) -
Acute rule-out of non–ST-segment elevation acute coronary syndrome in the (pre)hospital setting by HEART score assessment and a single point-of-care troponin: rationale and design of the ARTICA randomised trial
por: Aarts, Goaris W A, et al.
Publicado: (2020)